home > ict > winter 2006 > editor’s letter


Dear guest!

article: Editor’s Letter
format: Adobe Acrobat PDF file
cost: £


News and Press Releases

Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery

Crystal Lake, Illinois, October 31, 2022 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that it has delivered the first phase of its previously announced expansion program of approximately $180 million USD to meet growing customer capacity needs for injection system solutions. The multisite, international expansion project began in 2020 and is intended to significantly boost capacity across all product lines, ultimately enabling Aptar Pharma to produce over 10 billion injectable component units annually when completed.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement